Medical/Pharmaceuticals

Adagene Presents Interim Results Reinforcing Best-in-Class Profile of Masked anti-CTLA-4 SAFEbody® ADG126 (muzastotug) in Combination with Pembrolizumab in Metastatic Microsatellite-stable (MSS) Colorectal Cancer (CRC)

- Data from first tranche of MSS CRC patients treated with ADG126 10 mg/kg every three weeks (Q3W) in dose expansionshowed clinical benefit including confirmed responses at higher, more frequent and repeat doses of the anti-CTLA-4 therapy - - Preliminary survival analysis of ADG126 10 mg/kg do...

2024-01-17 20:00 4735

SeptiCyte RAPID® By Immunexpress Receives Regulatory Clearance from Australian Therapeutic Goods Administration (TGA)

The Cost of Sepsis in Australia report (2021) estimated that there are >90,000 sepsis cases inAustralia each year and estimated direct and indirect costs of $700 million and $4 billion respectively SEATTLE and BRISBANE, Australia, Jan. 17, 2024 /PRNewswire/ -- Immunexpress, Pty Ltd., a molecular...

2024-01-17 06:00 2699

FIRST PATIENTS ENROLLED IN THE GORE VBX FORWARD CLINICAL STUDY

This study aims to compare the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis primary patency to bare metal stenting to evaluate superiority in treating complex iliac occlusive disease with the goal of informing practice guidelines around which modality is best suited for patients with this...

2024-01-16 21:00 2318

Epitomee® Announces Successful Completion of Pivotal Clinical Trial for Innovative Weight Loss Capsule

CAESAREA, Israel, Jan. 16, 2024 /PRNewswire/ -- Epitomee® announces the successful completion of the RESET pivotal clinical trial, for its weight loss capsule. The randomized placebo controlled, double blind trial, investigated the safety and efficacy of Epitomee® capsule versus the sham capsule ...

2024-01-16 21:00 3332

HOPE FOR FEMALE CANCER PATIENTS TO PRESERVE FERTILITY THROUGH OVARIAN TISSUE CRYOPRESERVATION AT SUNFERT

Sunfert International Fertility Centre is the First Private Oncofertility Hub in Malaysia KUALA LUMPUR, Malaysia, Jan. 16, 2024 /PRNewswire/ -- Reproductive medicine has achieved groundbreaking milestones, andMalaysia is one of the countries that is sought after by couples near and far to realis...

2024-01-16 18:14 2498

TVM Capital Healthcare invests in Vietnamese Eye Care Business Alina Vision in a Growth-Buy Out Transaction

Alina Vision operates hospitals in the underserved Vietnamese ophthalmology market, providing affordable and high-quality eye care services for people across all income levels to combat avoidable blindness; and meeting the impact investing strategy of TVM Capital Healthcare SINGAPORE and HANOI, ...

2024-01-16 16:55 4080

International Diabetes Federation and Sanofi Global Health Unit collaborate to strengthen diabetes response in 40 countries

The partnership will enhance diabetes care through training aimed at building capacity among healthcare professionals in low and middle-income countries. BRUSSELS, Jan. 16, 2024 /PRNewswire/ -- The International Diabetes Federation (IDF) , in collaboration with Sanofi's Global H...

2024-01-16 15:00 2129

CELLSEARCH® CTC count proves its clinical utility in guiding therapeutic strategy supporting patient care in HR+/HER2- metastatic breast cancer

STIC CTC trial data published this November 2023 in the Journal of Clinical Oncology (JCO)demonstrate that CTC-guided treatment decision confers superior survival benefits in a subgroup of patients with hormone receptor (HR) positive)/human epidermal growth factor receptor (HER) 2 negative metast...

2024-01-16 15:00 2686

Brain Navi Announces 100th Surgical Procedure Completed Using NaoTrac

HSINCHU, Jan. 16, 2024 /PRNewswire/ -- Brain Navi announced the completion of the 100th case utilizing its neurosurgical navigation robot NaoTrac. The 100th case has been performed by Neurosurgery Department Director Dr. Hao-Yu Chuang at Annan Hospital in Tainan,Taiwan.

2024-01-16 11:03 4910

The Human Change campaign launched at World Economic Forum in Davos to make children's mental health a global priority

'Human change' is happening now, caused by the over-digitalization of children's lives –the world must prioritize the alignment of technological progress with the healthy development of children. DAVOS, Switzerland, Jan. 15, 2024 /PRNewswire/ -- Global advocacy campaign,  Human Change

2024-01-15 15:00 3928

NX China Takes Part in 9th Annual Medical Device Supply Chain Conference

TOKYO, Jan. 15, 2024 /PRNewswire/ -- Nippon Express (China) Co., Ltd. (hereinafter "NX China"), a group company of NIPPON EXPRESS HOLDINGS, INC., participated in the three-day 9th Annual Medical Device Supply Chain Conference held inChengdu, China, from November 25 to 27, 2023. Logo: https://kyo...

2024-01-15 14:00 3272

SOPHiA GENETICS and Karkinos Healthcare Forge Strategic Partnership to Advance Cancer Research in India

SOPHiA GENETICS technology helps advance cancer research across India SOPHiA GENETICS and Karkinos Healthcare join forces to propel cutting-edge genomic solutions for breakthroughs in personalized cancer care inIndia BOSTON and ROLLE, Switzerland, Jan. 15, 2024 /PRNewswire/ -- SOPHiA GENETICS (N...

2024-01-15 12:00 2797

Subject Enrollment Completed for International Multicenter Comparative Clinical (Phase 3) Study of Boan Biotech's Denosumab

A meeting was also held in Germany to announce the results of the international pharmacokinetic similarity clinical (Phase 1) study BERLIN, Jan. 12, 2024 /PRNewswire/ -- Boan Biotech recently announced that subject enrollment for the international multicenter comparative clinical (Phase 3) study...

2024-01-12 21:15 4578

RemeGen's RC88 Obtained FDA Fast Track Designation, Heralds New Hope for Ovarian Cancer Patients

YANTAI, China, Jan. 12, 2024 /PRNewswire/ -- RemeGen Co. Ltd. ("RemeGen" or "the Company") (9995.HK, 688331.SH), a commercial-stage biotechnology company, announced recently that its independently developed mesothelin (MSLN)-targeting antibody-drug conjugate (ADC), RC88, has been granted Fast Tra...

2024-01-12 18:17 3095

U.S. FDA Approves the VISUMAX 800 with SMILE pro software from ZEISS

The updated ZEISS femtosecond laser provides U.S. refractive surgeons with faster treatment, greater flexibility, and significant workflow enhancements. DUBLIN, Calif. and JENA, Germany, Jan. 11, 2024 /PRNewswire/ -- Carl Zeiss Meditec AG -- ZEISS Medical Technology announced today that the U.S. ...

2024-01-11 20:00 3713

CEO of Kelun-Biotech Dr. Micheal Ge delivered a presentation on The 42nd JPM Annual Healthcare Conference

SAN FRANCISCO, Jan. 11, 2024 /PRNewswire/ -- The 42nd J.P. Morgan Annual Healthcare Conference("JPMHC")2024 is taking place onJanuary 8-11 at San Fracisco,USA, members of Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (6990.HK, Kelun-Biotech) senior management team participated in the conferen...

2024-01-11 16:32 3480

A New Study Shows GlycoMark is a Novel Biomarker of SGLT-2i Adherence

RALEIGH, N.C., Jan. 10, 2024 /PRNewswire/ -- A new study, "1,5-Anhydroglucitol: A Novel Biomarker of Adherence in Sodium -Glucose Cotransporter 2 Inhibitors," was published online onDecember 13, 2023, in Diabetes Care, a journal from the American Diabetes Association. The study was conducted b...

2024-01-10 20:00 1899

More accurate tumour treatment thanks to superconductive ASG Superconductors technology

GENOA, Italy and DRESDEN, Germany, Jan. 10, 2024 /PRNewswire/ -- ASG Superconductors' (ASG) MgB2 superconducting technology - already in use for energy and medical applications such as the world's only truly open MROpenEVO magnetic resonance imaging (MRI) system - is at the heart of the worldwide...

2024-01-10 18:49 4074

Novogene Bolsters Global Presence with Expanded PacBio Revio Fleet, Advancing Long-Read Sequencing Applications

SINGAPORE, Jan. 10, 2024 /PRNewswire/ -- Novogene further expands its long-read sequencing capacity with the acquisition of six additional PacBio Revio sequencers, augmenting its fleet of multi-platforms sequencing technology. This strategic investment underline Novogene's commitment to enhancing...

2024-01-10 10:30 4867

Health Recovery Solutions (HRS) Applauded by Frost & Sullivan for Transforming Remote Care Delivery with Its Clinically Enabled, Patient-centric RPM Solutions

HRS's RPM solutions enhance patient outcomes and satisfaction, optimize hospital bed utilization, improve quality, reduce costs, and curb readmissions across diverse healthcare settings. SAN ANTONIO, Jan. 9, 2024 /PRNewswire/ -- Frost & Sullivan researched the remote patient monitoring (RPM) ind...

2024-01-09 23:00 2478
1 ... 199200201202203204205 ... 380